Record revenue for Bioxyne but cash deficit rises after flower investment by Steve Jones October 30, 2025November 3, 2025 Medicinal cannabis pastille manufacture, Bioxyne, delivered record revenue of more than A$14 million in the first […]
Cannabis executive salaries: who earned what in FY25 by Adam Sheldon October 22, 2025October 22, 2025
News in brief: The Entourage Effect named AFR innovation finalist; Bioxyne lists in Germany; Nimbin to host medical cannabis symposium by Steve Jones October 13, 2025February 21, 2026
‘It’s super exciting’ – Breathe Life Sciences secures ARTG listings for Dr Watson range by Adam Sheldon October 9, 2025October 13, 2025
Trump CBD video sparks US stock rally – and hope among local firms by Adam Sheldon October 1, 2025October 1, 2025
News in brief: Epsilon receives EU, UK GMP certificates; AGH raises $2.6m via placement; Zelira secures loan notes; Bioxyne’s $5m German order by Steve Jones September 17, 2025February 21, 2026
Bioxyne swings to first significant profit on surging domestic sales by Adam Sheldon August 29, 2025August 29, 2025
News in brief: Wragg joins ANTG; Bioxyne launches legal claim; Epsilon appoints Kaplon by Martin Lane August 28, 2025February 21, 2026
Bioxyne shares spike after upgrade to FY25 revenue forecast by Adam Sheldon June 12, 2025June 12, 2025
Bioxyne stays on course to hit A$25m revenue guidance despite Q3 fall by Steve Jones April 28, 2025April 28, 2025
